Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Pulse Wave vs Saline Bolus EIT to measure lung perfusion in ARDS

Official title: Pulse Wave Method Versus Saline Contrast Pulmonary Perfusion EIT Imaging for Detecting Pulmonary Perfusion in ARDS Patients: a Prospective Observational Study

Run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · NCT07908368 · Data updated 2026-11-12

This study tests whether pulse wave EIT or saline bolus EIT can best show lung blood flow in ARDS patients on mechanical ventilation.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedDecember 22, 2025
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07908368 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-80 with ARDS on mechanical ventilation, and with a subclavian or internal jugular venous catheter in place.

Probably not a fit

Patients with major comorbidities or conditions listed in the exclusion criteria may not experience any perfusion-imaging benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares two electrical impedance tomography (EIT) methods—pulse wave EIT and saline bolus EIT—for assessing pulmonary perfusion in adults with ARDS who are mechanically ventilated. It also explores how different positive end-expiratory pressure (PEEP) levels affect perfusion imaging accuracy. Real-time, bedside imaging aims to enhance understanding of ventilation-perfusion status to support individualized, precision care. The trial leverages noninvasive EIT signals to monitor dynamic cardiopulmonary physiology during critical illness. Participants meet criteria typical for severe ARDS requiring intubation and venous access, with exclusions to minimize risk and confounding conditions.

Why it matters

Potential benefit: If successful, the approach could provide clinicians with a noninvasive, real-time way to monitor pulmonary perfusion to guide treatment decisions in ARDS.

How similar studies have gone: Previous uses of EIT for ventilation are established; perfusion imaging is more exploratory but has shown promise in pilot studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 18-80 years;
2. Endotracheal intubation and mechanical ventilation;
3. Presence of a subclavian or internal jugular venous catheter in place;
4. Diagnosis of ARDS according to the 2023 global ARDS definition.

Exclusion Criteria:

1. Age \<18 or \>80 years;
2. Severe obesity (BMI ≥35 kg/m²);
3. Pregnant or lactating women;
4. Pulmonary diseases: acute asthma exacerbation, COPD, pulmonary fibrosis, pleural effusion, pneumothorax, or pulmonary embolism;
5. Cardiac diseases: arrhythmias, significant valvular regurgitation, or cardiac dysfunction (LVEF \<50% or right ventricular dysfunction);
6. Hypernatremia;
7. Receiving ECMO therapy;
8. Failure to provide informed consent.

Where it's running

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.